SXTC Live signaler | Maksimer profitt med Getagraph.com

SELG 117069 min ago

@ $2.15

Utstedt: 14 feb 2024 @ 19:52

Avkastning: -55.32%

Forrige signal: feb 14 - 15:31

Forrige signal: Kjøp

Avkastning: 13.46 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China...

Stats
Dagens volum	224 228
Gjennomsnittsvolum	1.14M
Markedsverdi	10.03M
EPS	$0 ( 2023-10-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.480
ATR14	$0.00500 (0.52%)

Volum Korrelasjon

Lang: 0.12 (neutral)

Kort: -0.69 (moderate negative)

Signal:(46.338) Neutral

China SXT Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
SIRI	0.87
LSXMA	0.856
LSXMK	0.854
CVBF	0.846
MCMJ	0.846
BMRC	0.839
TVACW	0.838
BSRR	0.838
FGBI	0.838
ESSA	0.837

10 Mest negative korrelasjoner
BLPH	-0.864
INTA	-0.861
MLTX	-0.846
MNDY	-0.838
FSLR	-0.838
LRMR	-0.83
DUOL	-0.828
RIVE	-0.828
DSEY	-0.828
PLYA	-0.824

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

China SXT Pharmaceuticals Korrelasjon - Valuta/Råvare

0.07
( neutral )

0.54
( weak )

0.00
( neutral )

-0.49
( neutral )

China SXT Pharmaceuticals Økonomi

Annual	2023
Omsetning:	$1.97M
Bruttogevinst:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2023
Omsetning:	$1.97M
Bruttogevinst:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2022
Omsetning:	$2.60M
Bruttogevinst:	$1.25M (48.10 %)
EPS:	$-5.52

FY	2021
Omsetning:	$4.78M
Bruttogevinst:	$2.84M (59.43 %)
EPS:	$-0.191

Financial Reports:

No articles found.

China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.